×

We've got news for you.

Register on BusinessLIVE at no cost to receive newsletters, read exclusive articles & more.
Register now

New Delhi — India is struggling to convince its health and front-line workers to take a homegrown Covid-19 vaccine controversially approved without late-stage efficacy data, government data showed on Thursday, days ahead of a wider rollout.

The country has the world’s second-highest number of Covid-19 infections after the US, with cases recently surging as mask-wearing declines and states have eased social-distancing measures. A lack of confidence in a homegrown vaccine country could prevent India from meeting its target of vaccinating 300-million of its 1.35-billion people by August...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now

Would you like to comment on this article?
Register (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.

Commenting is subject to our house rules.